Guarini Kathryn

Director at REGN

Sold, on record
$660k
Dollars the filings state
Form 4 sales
2
Latest Sep 2, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • REGNREGENERON PHARMACEUTICALS, INC.Director

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice REGNNotice
    Aug 10, 2026 2026

    Filed to sell 400 shares ($320k)

    Guarini Kathryn, Board member

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale REGNRoutine
    Aug 10, 2026 same day

    Sold 400 shares at $800.00 ($320k)

    Guarini Kathryn, Director

    10b5-1 planSold 39.9% of holdings ($802k position)603 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice REGNNotice
    Sep 2, 2026 +23 days

    Filed to sell 400 shares ($340k)

    Guarini Kathryn, Director

    10b5-1 planFiling

  4. 4 Form 4 sale REGNRoutine
    Sep 2, 2026 same day

    Sold 400 shares at $850.00 ($340k)

    Guarini Kathryn, Director

    10b5-1 planSold 39.9% of holdings ($853k position)603 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Guarini Kathryn
Source
Sep 2, 2026Sep 3, 2026REGNDirectorForm 4 sale400$340k39.9%RoutineSEC
Sep 2, 2026Sep 2, 2026REGNDirectorForm 144 notice400$340kNoticeSEC
Aug 10, 2026Aug 12, 2026REGNDirectorForm 4 sale400$320k39.9%RoutineSEC
Aug 10, 2026Aug 10, 2026REGNBoard memberForm 144 notice400$320kNoticeSEC